NCT01386567View on ClinicalTrials.gov

A One Year Open Label Study for the Treatment of Hypogonadism (Low Testosterone) in Men Who Have Completed ZA-203

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions

HypogonadismLow Testosterone

Interventions

DRUG

Androxal (enclomiphene citrate)

"capsules oral 1x a day~1 year"

DRUG

Testim (topical testosterone)

"topical~1 tube~1x a day~1 year"

Trial Locations (8)

77024

Houston

77062

Houston

77095

Houston

89109

Las Vegas

89144

Las Vegas

92108

San Diego

92844

Garden Grove

95821

Sacramento

All Listed Sponsors

lead

Repros Therapeutics Inc.

INDUSTRY

NCT01386567 - A One Year Open Label Study for the Treatment of Hypogonadism (Low Testosterone) in Men Who Have Completed ZA-203 | Biotech Hunter | Biotech Hunter